All In Biotech

Drug Trial Radar · NCT06061549

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

A Phase 1b, Pilot Trial Evaluating the Safety and Pharmacodynamic Effects of SRD-001 (AAV1-SERCA2a) in Subjects With Heart Failure With Preserved Ejection Fraction

Last checked: Nov 19, 2026Latest source record: Sep 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Aug 24, 2023

Primary completion

Aug 2025

Study completion Aug 2029

Sponsor

Lead sponsor
Sardocor Corp.Industry
Sponsor type
Industry
First posted
Sep 29, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to test an experimental gene therapy in participants with heart failure with preserved ejection fraction, also known as diastolic heart failure. The main questions it aims to answer are: * safety and tolerability of the gene therapy; and * whether the gene therapy helps the heart ventricles relax during filling. Participants will undergo a one-time infusion of the gene therapy in the cardiac catheterization laboratory and then be followed for safety and effects on left-sided filling pressures while exercising. The first year will have multiple in-person visits followed by 4 years of biannual phone calls.

Conditions

  • Heart Failure, Diastolic
  • Heart Failure With Preserved Ejection Fraction

Interventions

  • AAV1/SERCA2aBiological

    3E13 viral genomes fixed dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in pulmonary capillary wedge pressure (PCWP)Time frame: Week 24 and Week 52

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Duke University

    Durham, North Carolina · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.